Zhengzhou Maidai Si Cross-Border E-Commerce Co., Ltd. – Trademark Portfolio

Entity Type: 99

Zhengzhou Maidai Si Cross-Border E-Commerce Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 2 Nice Classification classes. Currently, 0 trademarks are registered and 1 is pending. The owner is based in Zhengzhou, Henan.

Meijinglongtang District

2802, 28/F, Unit 1, Building 9, Vanke

Zhengzhou, Henan 450000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Zhengzhou Maidai Si Cross-Border E-Commerce Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

16
Paper Goods (1 filing)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Frequently Asked Questions

How many trademarks does Zhengzhou Maidai Si Cross-Border E-Commerce Co., Ltd. have?

Zhengzhou Maidai Si Cross-Border E-Commerce Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 pending, 1 abandoned.

What trademark classes does Zhengzhou Maidai Si Cross-Border E-Commerce Co., Ltd. file in?

Zhengzhou Maidai Si Cross-Border E-Commerce Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 16 (Paper Goods). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What is Zhengzhou Maidai Si Cross-Border E-Commerce Co., Ltd.'s trademark registration success rate?

Zhengzhou Maidai Si Cross-Border E-Commerce Co., Ltd. has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.